Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
This Quarter Return
-3.83%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$25.3B
AUM Growth
+$148M
(+0.59%)
Cap. Flow
+$1.79B
Cap. Flow
% of AUM
7.08%
Top 10 Holdings %
Top 10 Hldgs %
25.95%
Holding
1,163
New
28
Increased
840
Reduced
173
Closed
12
Top Buys
| 1 |
Apple
AAPL
|
$130M |
| 2 |
Microsoft
MSFT
|
$113M |
| 3 |
Amazon
AMZN
|
$71.2M |
| 4 |
Tesla
TSLA
|
$59.6M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$40.3M |
Top Sells
Sector Composition
| 1 | Technology | 25.81% |
| 2 | Healthcare | 12.82% |
| 3 | Consumer Discretionary | 11.77% |
| 4 | Financials | 11.55% |
| 5 | Communication Services | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Codexis
CDXS
$218M
| $175K | ﹤0.01% |
8,483
+749
| +10% | +$15.5K |
|
1077
Marqeta
MQ
$2.77B
| $173K | ﹤0.01% |
15,710
+1,819
| +13% | +$20K |
|
1078
Editas Medicine
EDIT
$225M
| $170K | ﹤0.01% |
8,939
+1,009
| +13% | +$19.2K |
|
1079
Ligand Pharmaceuticals
LGND
$3.25B
| $169K | ﹤0.01% |
2,413
+252
| +12% | +$17.6K |
|
|
LX
1080
LexinFintech Holdings
LX
$1.02B
| $167K | ﹤0.01% |
63,565
+4,046
| +7% | +$10.6K |
|
1081
Simulations Plus
SLP
$289M
| $166K | ﹤0.01% |
+3,248
| New | +$166K |
|
1082
Intellia Therapeutics
NTLA
$1.26B
| $165K | ﹤0.01% |
2,272
+140
| +7% | +$10.2K |
|
1083
Repare Therapeutics
RPTX
$73.9M
| $165K | ﹤0.01% |
11,580
+1,002
| +9% | +$14.3K |
|
1084
Inovio Pharmaceuticals
INO
$144M
| $161K | ﹤0.01% |
3,737
+408
| +12% | +$17.6K |
|
1085
Atara Biotherapeutics
ATRA
$88.7M
| $160K | ﹤0.01% |
689
+44
| +7% | +$10.2K |
|
|
TSVT
1086
DELISTED
2seventy bio
TSVT
| $160K | ﹤0.01% |
9,364
+1,089
| +13% | +$18.6K |
|
1087
Ebang International Holdings
EBON
$25.6M
| $159K | ﹤0.01% |
4,579
+377
| +9% | +$13.1K |
|
|
MILE
1088
DELISTED
Metromile, Inc. Common Stock
MILE
| $158K | ﹤0.01% |
119,788
+14,865
| +14% | +$19.6K |
|
1089
AbCellera Biologics
ABCL
$1.19B
| $156K | ﹤0.01% |
16,008
+1,854
| +13% | +$18.1K |
|
|
AYX
1090
DELISTED
Alteryx, Inc.
AYX
| $156K | ﹤0.01% |
+2,181
| New | +$156K |
|
1091
CureVac
CVAC
$1.21B
| $155K | ﹤0.01% |
7,888
+886
| +13% | +$17.4K |
|
1092
Agilysys
AGYS
$2.98B
| $154K | ﹤0.01% |
3,861
+430
| +13% | +$17.2K |
|
1093
Q2 Holdings
QTWO
$4.83B
| $154K | ﹤0.01% |
2,497
+295
| +13% | +$18.2K |
|
|
ADAP
1094
Adaptimmune Therapeutics
ADAP
$13.9M
| $153K | ﹤0.01% |
74,256
+5,116
| +7% | +$10.5K |
|
|
CLLS
1095
Cellectis
CLLS
$260M
| $153K | ﹤0.01% |
33,595
+1,988
| +6% | +$9.05K |
|
|
AVYA
1096
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $153K | ﹤0.01% |
+12,053
| New | +$153K |
|
1097
IDT Corp
IDT
$1.64B
| $152K | ﹤0.01% |
+4,447
| New | +$152K |
|
|
WPRT
1098
Westport Fuel Systems
WPRT
$47.2M
| $151K | ﹤0.01% |
+9,571
| New | +$151K |
|
|
CTO
1099
CTO Realty Growth
CTO
$564M
| $146K | ﹤0.01% |
6,609
| – | – |
|
1100
LendingClub
LC
$1.88B
| $145K | ﹤0.01% |
9,195
+826
| +10% | +$13K |
|